Market Overview

ATI and Bruker Announce Agreement to Further Advance Niobium-Based Superconductor Technology and Manufacturing Processes

Share:

Allegheny Technologies Incorporated (NYSE:ATI) and Bruker Energy &
Supercon Technologies (BEST), a wholly owned subsidiary of Bruker
Corporation, today announced that they have entered into a joint
technology development agreement to advance state-of-the-art
niobium-based superconductors, including those used in magnetic
resonance imaging (MRI) magnets for the medical industry, and
preclinical MRI magnets used in the life-science tools industry.

Built on a 30-year collaboration between the two companies, this
agreement further extends their tremendous combined expertise to develop
higher-performance niobium-based alloys and apply these alloys in
improved and more efficient superconductors, which are expected to
enable MRI magnets with higher performance and lower total cost of
ownership. The resulting products are expected to have applications in
medical imaging, scientific instrumentation, particle physics research,
and large-scale fusion experiments to produce energy. The advanced
manufacturing and metrology processes, as well as the highly
differentiated new superconductors planned under this agreement will
deliver higher performance, ultimately aiming to give healthcare
providers better diagnostics to improve lives. At the same time, the
fully integrated supply chain will allow for process innovation to even
further increase efficiency, quality and supply chain security for
demanding customers.

Bruker Energy & Supercon Technologies is a leading manufacturer of
highest performance superconducting wire products with a product
portfolio that includes high-quality niobium-based superconductors. With
more than 50 years of experience in the field of superconducting wire,
BEST offers a unique and broad superconductor technology spectrum, a
highly automated superconductor factory with the most advanced and
integrated metrology capabilities to ensure highest conductor yield,
quality and on-time deliveries. BEST has invested heavily in these
unique capabilities over the last decade in order to meet a wide range
of requirements for healthcare, industrial and research applications.

"This long-term agreement further strengthens the extensive cooperation
between ATI and Bruker," commented Dr. Burkhard Prause, President of
BEST. "We believe this collaboration will further advance the combined
expertise within our businesses to create new and improved
superconductor products and deliver enhanced commercial value for our
healthcare and life science customers."

ATI, a global leader in refractory metal production and manufacturer of
specialty alloys, materials, and components, brings more than 50 years
of experience as a leading manufacturer of niobium-titanium and other
specialty alloys for medical and high-energy physics applications. "ATI
has long led the industry with its technical expertise and
differentiated manufacturing capability for niobium-based alloys for
superconductors," said Lee Weber, President of ATI Specialty Alloys and
Components. "This new agreement expands our collaboration, so we may
create the specialty materials that will propel the industry. The
Relentless Innovation™ for which ATI is known is truly saving lives and
improving the future for generations to come."

Forward-Looking Statements

This news release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995. Certain
statements in this news release relate to future events and expectations
and, as such, constitute forward-looking statements. Forward-looking
statements, which may contain such words as "anticipates," "believes,"
"estimates," "expects," "would," "should," "will," "will likely result,"
"forecast," "outlook," "projects," and similar expressions, are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which we are unable to predict
or control. Our performance or achievements may differ materially from
those expressed or implied in any forward-looking statements due to the
following factors, among others: (a) material adverse changes in
economic or industry conditions generally, including global supply and
demand conditions and prices for our specialty metals; (b) material
adverse changes in the markets we serve; (c) our inability to achieve
the level of cost savings, productivity improvements, synergies, growth
or other benefits anticipated by management from strategic investments
and the integration of acquired businesses; (d) volatility in the price
and availability of the raw materials that are critical to the
manufacture of our products; (e) declines in the value of our defined
benefit pension plan assets or unfavorable changes in laws or
regulations that govern pension plan funding; (f) labor disputes or work
stoppages; (g) equipment outages and (h) other risk factors summarized
in our Annual Report on Form 10-K for the year ended December 31, 2017,
and in other reports filed with the Securities and Exchange Commission.
We assume no duty to update our forward-looking statements.

About Bruker Corporation

Bruker is enabling scientists to make breakthrough discoveries and
develop new applications that improve the quality of human life.
Bruker's high-performance scientific instruments and high-value
analytical and diagnostic solutions enable scientists to explore life
and materials at molecular, cellular and microscopic levels. In close
cooperation with our customers, Bruker is enabling innovation, improved
productivity and customer success in life science molecular research, in
applied and pharma applications, in microscopy and nanoanalysis, and in
industrial applications, as well as in cell biology, preclinical
imaging, clinical phenomics and proteomics research and clinical
microbiology. For more information, please visit: www.bruker.com.

Creating Value Thru Relentless Innovation™

ATI is a global manufacturer of technically advanced specialty materials
and complex components. ATI revenue was $3.9 billion for the
twelve-month period ended September 30, 2018. Our largest markets are
aerospace & defense, particularly jet engines. We also have a strong
presence in the oil & gas, electrical energy, medical, automotive, and
other industrial markets. ATI is a market leader in manufacturing
differentiated specialty alloys and forgings that require our unique
manufacturing and precision machining capabilities and our innovative
new product development competence. We are a leader in producing powders
for use in next-generation jet engine forgings and 3D-printed aerospace
products. See more at our website ATIMetals.com.

View Comments and Join the Discussion!